Neurotec Pharma logo — Advancing Novel Treatments for CNS Diseases through Microgli...

Neurotec Pharma

Advancing Novel Treatments for CNS Diseases through Microglia Cell Innovation

Founded 2006 Venture round Total: $3.30M Biopharma, Biotechnology +1

General Information

Company Name Neurotec Pharma
Founded Year 2006
Founders / Decision Makers
Team member
Industries Biopharma, Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Neurotec Pharma. To contact Neurotec Pharma, visit neurotec-pharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Neurotec Pharma

Neurotec Pharma is a biopharma and biotechnology startup that is committed to Advancing Novel Treatments for CNS Diseases through Microglia Cell Innovation. Founded in 2006 as a spin-off from the University of Barcelona, it operates from the Parc Científic de Barcelona. The company's primary focus lies in developing innovative treatments for acute and chronic Central Nervous System (CNS) diseases by controlling the activity of microglia cells, which play a pivotal role in various diseases related to inflammation or acute cerebral damage. In February 2011, Neurotec Pharma secured a significant €3.30M Venture Round investment. The investors involved in this round were Inveready and Fundación Caja Navarra. This backing demonstrates investor confidence in the potential of Neurotec Pharma's approach and its capability to address unmet medical needs in CNS diseases.

Taxonomy: Neurotec Pharma, University of Barcelona, Parc Científic de Barcelona, CNS diseases, microglia cells, acute cerebral damage, inflammation, neurological treatments, biomedical innovation, spin-off, biotech startup, medical research, neuroscience, drug development

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round €3.30M 2
Inveready, Fundación Caja Navarra
19 Feb 2011

Neurotec Pharma Alternatives & Competitors

Neurotec Pharma vs

We develop new selective and potent drugs for intrinsically disordered targets.

22 employees
Biopharma, Biotechnology
Neurotec Pharma vs

Towards an efficacious and well-tolerated appetite-suppressant using our innovative in-vivo screenin...

Seed
6 employees
Biotechnology, Health Care
Neurotec Pharma vs

Pioneering regenerative solutions for joint health and mobility.

Private Equity
Biotechnology, Health Care

FAQ About Neurotec Pharma

Advancing Novel Treatments for CNS Diseases through Microglia Cell Innovation
Neurotec Pharma was founded in 2006.
Neurotec Pharma operates in Biopharma, Biotechnology and Health Care. Its work centres on Neurotec Pharma, University of Barcelona, Parc Científic de Barcelona and CNS diseases.
Neurotec Pharma has completed 1 funding round, raising a total of $3.30M. The latest funding stage is Venture round.
Top alternatives and competitors to Neurotec Pharma include Nuage Therapeutics, EraCal Therapeutics , TiGenix, Pinteon Therapeutics, Acticor Biotech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neurotec Pharma and Nuage Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Neurotec Pharma, https://bouncewatch.com/company/neurotec-pharma, updated 11 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes